PET/CT in oncology—a major advance
K. Wechalekar, B. Sharma and G. Cook
The concept of hardware fusion between positron emission tomography (PET) and computed tomography (CT) has only been introduced commercially in the last 4 years. The advantages of this combined technique over PET alone have become obvious. There is increasing evidence to suggest that PET/CT adds complementary information in staging, re-staging and follow-up in oncology patients, leading to changes in management plans. The present paper is a review of the strengths, weaknesses, current evidence and future directions of this technique.
Keywords: 18F-fluorodeoxyglucose; Positron emission tomography/computed tomography (PET/CT); Oncology
Full article at-
No comments:
Post a Comment